EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials

DOI: 10.2147/OTT.S174593

Keywords: adjuvant treatment, EGFR tyrosine kinase inhibitors, non-small-cell lung cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text